These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 9713282)
21. Increased expression of human ribosomal phosphoprotein P0 messenger RNA in hepatocellular carcinoma and colon carcinoma. Barnard GF; Staniunas RJ; Bao S; Mafune K; Steele GD; Gollan JL; Chen LB Cancer Res; 1992 Jun; 52(11):3067-72. PubMed ID: 1350508 [TBL] [Abstract][Full Text] [Related]
22. Isolation of differentially expressed genes in carcinoma of the esophagus. Graber MW; Schweinfest CW; Reed CE; Papas TS; Baron PL Ann Surg Oncol; 1996 Mar; 3(2):192-7. PubMed ID: 8646521 [TBL] [Abstract][Full Text] [Related]
23. cDNA cloning of new protein tyrosine phosphatases in the human colon. Arimura Y; Hinoda Y; Itoh F; Takekawa M; Tsujisaki M; Adachi M; Imai K; Yachi A Tumour Biol; 1992; 13(3):180-6. PubMed ID: 1626183 [TBL] [Abstract][Full Text] [Related]
24. Increased lipid peroxidation, apoptosis and selective cytotoxicity in colon cancer cell line LoVo and its doxorubicin-resistant subline LoVo/Dx in the presence of newly synthesized phenothiazine derivatives. Środa-Pomianek K; Michalak K; Świątek P; Poła A; Palko-Łabuz A; Wesołowska O Biomed Pharmacother; 2018 Oct; 106():624-636. PubMed ID: 29990852 [TBL] [Abstract][Full Text] [Related]
25. Expression of c-kit and kit ligand in human colon carcinoma cells. Toyota M; Hinoda Y; Takaoka A; Makiguchi Y; Takahashi T; Itoh F; Imai K; Yachi A Tumour Biol; 1993; 14(5):295-302. PubMed ID: 7694350 [TBL] [Abstract][Full Text] [Related]
26. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells. Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311 [TBL] [Abstract][Full Text] [Related]
27. Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas. Violette S; Festor E; Pandrea-Vasile I; Mitchell V; Adida C; Dussaulx E; Lacorte JM; Chambaz J; Lacasa M; Lesuffleur T Int J Cancer; 2003 Jan; 103(2):185-93. PubMed ID: 12455032 [TBL] [Abstract][Full Text] [Related]
28. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. Ross DD; Yang W; Abruzzo LV; Dalton WS; Schneider E; Lage H; Dietel M; Greenberger L; Cole SP; Doyle LA J Natl Cancer Inst; 1999 Mar; 91(5):429-33. PubMed ID: 10070941 [TBL] [Abstract][Full Text] [Related]
29. Induction of MRP5 and SMRP mRNA by adriamycin exposure and its overexpression in human lung cancer cells resistant to adriamycin. Yoshida M; Suzuki T; Komiya T; Hatashita E; Nishio K; Kazuhiko N; Fukuoka M Int J Cancer; 2001 Nov; 94(3):432-7. PubMed ID: 11745426 [TBL] [Abstract][Full Text] [Related]
30. Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity. Ohnami S; Matsumoto N; Nakano M; Aoki K; Nagasaki K; Sugimura T; Terada M; Yoshida T Cancer Res; 1999 Nov; 59(21):5565-71. PubMed ID: 10554036 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb. Melani C; Rivoltini L; Parmiani G; Calabretta B; Colombo MP Cancer Res; 1991 Jun; 51(11):2897-901. PubMed ID: 2032228 [TBL] [Abstract][Full Text] [Related]
32. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells]. Li CY; Yao AM; Chang XN; Guo YH; Xu R Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958 [TBL] [Abstract][Full Text] [Related]
33. Application of mRNA differential display to investigate gene expression in thermotolerant cells of Saccharomyces cerevisiae. Gross C; Watson K Yeast; 1998 Mar; 14(5):431-42. PubMed ID: 9559551 [TBL] [Abstract][Full Text] [Related]
34. Complementary DNA cloning and characterization of truncated form of c-kit in human colon carcinoma cells. Toyota M; Hinoda Y; Itoh F; Takaoka A; Imai K; Yachi A Cancer Res; 1994 Jan; 54(1):272-5. PubMed ID: 7505199 [TBL] [Abstract][Full Text] [Related]
35. Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation. Kondoh N; Schweinfest CW; Henderson KW; Papas TS Cancer Res; 1992 Feb; 52(4):791-6. PubMed ID: 1339304 [TBL] [Abstract][Full Text] [Related]
36. Incomplete processing of progastrin expressed by human colon cancer cells: role of noncarboxyamidated gastrins. Singh P; Xu Z; Dai B; Rajaraman S; Rubin N; Dhruva B Am J Physiol; 1994 Mar; 266(3 Pt 1):G459-68. PubMed ID: 8166285 [TBL] [Abstract][Full Text] [Related]
38. Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line. Hochhauser D; Schnieders B; Ercikan-Abali E; Gorlick R; Muise-Helmericks R; Li WW; Fan J; Banerjee D; Bertino JR J Natl Cancer Inst; 1996 Sep; 88(18):1269-75. PubMed ID: 8797766 [TBL] [Abstract][Full Text] [Related]
39. Identification of differentially expressed mRNA transcripts in drug-resistant versus parental human melanoma cell lines. Tanic N; Brkic G; Dimitrijevic B; Dedovic-Tanic N; Gefen N; Benharroch D; Gopas J Anticancer Res; 2006; 26(3A):2137-42. PubMed ID: 16827156 [TBL] [Abstract][Full Text] [Related]
40. Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line. Son YS; Suh JM; Ahn SH; Kim JC; Yi JY; Hur KC; Hong WS; Muller MT; Chung IK Cancer Chemother Pharmacol; 1998; 41(5):353-60. PubMed ID: 9523730 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]